Although pain is a major clinical, social, and economic problem that affects the quality of life of hundreds of millions of people around the world, the measurement of pain remains subjective. As a result, pain care is not tailored to the specific needs of patients, opioid addiction has become an epidemic, and the direct costs of pain-related medical care are skyrocketing.

By addressing this problem, Medasense's NOL® technology enables clinicians to personalize pain management, optimize treatment, and avoid overmedication with an innovative platform of non-invasive sensors and AI technology. Distributed by MEDTRONIC in Europe.